Brimonidine (Alphagan P, Alphagan) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 29, 2026
Some Brimonidine products are in shortage in Canada (2 of 9 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 28, 2026.
An eye drop used to lower pressure inside the eye in glaucoma and ocular hypertension.
Products affected
2 / 9
In shortage since
Mar 24, 2026
Est. full return
Aug 28, 2026
Reports on file
46
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP BRIMONIDINE
0.2% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02449226 · since Jun 17, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Active shortage
BRIMONIDINE P
0.15% · SOLUTION · AA PHARMA INC
DIN 02301334 · since May 5, 2026, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
Active shortage
BRIMONIDINE P
0.15% · SOLUTION · AA PHARMA INC
DIN 02301334 · since Mar 24, 2026, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
Anticipated
ALPHAGAN
0.2% · SOLUTION
LIQUID · ABBVIE CORPORATION
DIN 02236876 · Demand increase for the drug.
Resolved
JAMP BRIMONIDINE
0.2% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02449226 · ended May 12, 2026 · Increase in demand - Allocation
Resolved
SANDOZ BRIMONIDINE
0.2% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02305429 · ended Mar 9, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ BRIMONIDINE
0.2% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02305429 · ended Jan 30, 2026 · Disruption of the manufacture of the drug.
Resolved
BRIMONIDINE P
0.15% · SOLUTION · AA PHARMA INC
DIN 02301334 · ended Nov 4, 2025 · Disruption of the manufacture of the drug.
Resolved
MED-BRIMONIDINE
0.2% · SOLUTION · GENERIC MEDICAL PARTNERS INC
DIN 02507811 · ended Nov 15, 2022 · Demand increase for the drug.
Resolved
BRIMONIDINE P
0.15% · SOLUTION · AA PHARMA INC
DIN 02301334 · ended Jun 24, 2025 · Disruption of the manufacture of the drug.
Discontinued
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION
0.2% · SOLUTION · HIKMA CANADA LIMITED
DIN 02515377
Discontinued
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION
0.2% · SOLUTION · HIKMA CANADA LIMITED
DIN 02515377
Showing 12 of 46 reports. All reports are on file with Health Canada.
What's happening
Brimonidine is currently affected by 2 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, AA PHARMA INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Brimonidine is classified under “ANTIGLAUCOMA PREPARATIONS AND MIOTICS” (ATC S01EA).
Recent changes
Jul 29, 2026
Estimated end date moved earlier : Jan 15, 2027 → Aug 28, 2026
Jul 21, 2026
New report filed
Common questions
What is Brimonidine used for?
An eye drop used to lower pressure inside the eye in glaucoma and ocular hypertension.
When will Brimonidine be back in stock in Canada?
The latest manufacturer estimate is Aug 28, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Brimonidine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.